These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32613146)

  • 21. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D; Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
    Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.
    Xiao L; Patrick DM; Aden LA; Kirabo A
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():48-53. PubMed ID: 30278231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
    May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
    J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Imaging of Preamyloid Oligomers, a Novel Structural Abnormality, in Human Atrial Samples.
    Sidorova TN; Mace LC; Wells KS; Yermalitskaya LV; Su PF; Shyr Y; Byrne JG; Petracek MR; Greelish JP; Hoff SJ; Ball SK; Glabe CG; Brown NJ; Barnett JV; Murray KT
    J Histochem Cytochem; 2014 Jul; 62(7):479-87. PubMed ID: 24789805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.
    Zografos TA; Katritsis DG
    Arrhythm Electrophysiol Rev; 2013 Nov; 2(2):109-14. PubMed ID: 26835050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation.
    Hasegawa Y; Okada S; Sanada A; Tomii A; Sugiura H; Higuchi K; Chinushi M; Inomata T
    Intern Med; 2023 Nov; 62(22):3283-3290. PubMed ID: 36823080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
    Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
    Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
    Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
    Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
    Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
    Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.
    Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA
    J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction.
    Ngwenyama N; Kirabo A; Aronovitz M; Velázquez F; Carrillo-Salinas F; Salvador AM; Nevers T; Amarnath V; Tai A; Blanton RM; Harrison DG; Alcaide P
    Circulation; 2021 Mar; 143(12):1242-1255. PubMed ID: 33463362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
    Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
    High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.